This review highlights how gut microbiota affects immune responses in cancer treatments, suggesting microbiota-based strategies may enhance immunotherapy.
Key Points
Gut microbiota plays a crucial role in determining the success of cancer immunotherapy treatments.
Clinical and preclinical studies indicate that microbiota-based strategies improve immune response and treatment efficacy.
Interventions such as FMT and probiotics show promise in reducing adverse immune-related events during therapy.
Advancing microbiota-focused therapies could refine precision immunotherapy approaches for cancer patients.